Read the full text of the Op-Ed: Our STAT Op-Ed: Drug Importation Can’t Coexist with U.S. Track-and-Trace Law - DrugChannels.net
From the Op-Ed:"As we see it, there is no legal or operational way of transforming a drug packaged for a foreign market into a drug that meets the U.S. requirements of our in-progress track-and-trace system. What’s more, there is no way to alter the law to enable importation without undermining the law’s purpose and value. ...
Importation laws undermine the country’s progress in building a modern technology infrastructure to track and trace prescription drugs. Making exceptions to the in-progress track-and-trace system would ignore the many instances of drug diversion and counterfeiting that led to the creation and passage of the law in 2013."
The Op-Ed covers the following areas:
- State drug importation laws undermine the process that keeps our supply chain safe
- Why the U.S. is building a track-and-trace system
- How track-and-trace works
- Importation undermines the track-and-trace system
- Importation enables counterfeits
- Forgetting the lessons
--------------
For Designated Representative license applicants - Training programs, courses, classes, seminars:
California (earn a training affidavit):- CA Designated Representative Wholesaler Training - Available around-the-clock 24 x 7
- CA Designated Representative 3PL Training
- CA Designated Representative Reverse Distributor Training - New!
- The Designated Representative Institute
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.